跳至主要内容
临床试验/PACTR201311000700893
PACTR201311000700893尚未招募未知

Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia (4P) ¿ a randomised, placebo-controlled, double-blind clinical trial.

niversity Medical Center Utrecht0 个研究点目标入组 440 人开始时间: 2013年11月8日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
440

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 99 Year(s)(—)
性别
Female

入选标准

  • <16 weeks of gestation and over 18 years of age,
  • - Intention to have subsequent antenatal visits and delivery at the same clinic.
  • - Can receive text messages by phone or through the phone of a proxy.
  • - A moderate to high risk (>20%) of developing PIH

排除标准

  • - Pre-existing hypertension or hypertension before 20 weeks gestation.
  • - Likely non-compliance with the protocol in view of the treating physician
  • - Comorbidity interfering with the protocol
  • - Known contraindications to Investigational Product components

研究者

相似试验